Past Events

In this SPARK Europe Webinar, Prof. Dr. Craig Garner will share his experience implementing design thinking to foster creativity, collaboration, and human-centered solutions to tackle complex challenges in areas like healthcare, biotechnology, and research.

In this SPARK Europe Webinar, Dr. Ingo Schroeter will explain why we need more researchers rather than business experts in the biotech industry.

Curie.Bio was founded to liberate biotech entrepreneurs, offering a model designed to maximize their ability to create transformative medicines while minimizing long-term equity dilution.

In this webinar, we will explore the AI Acts in both Europe and the USA, focusing on their broad implications for software and algorithm development in healthcare.

In this Online SPARK Europe Webinar "Telik Story: The rise and fall of a biotech company", Steve Schow, PhD will tell the 21-year tale of the birth, rise and demise of Telik, which at one point, was valued at ~$1.5 billon USD.

In this Online SPARK Europe Webinar "From PhD to CEO: why I want to make an impact in science or business", Dr. med. Verena Schöwel will share her journey from clinical practice to co-founding the biotech company MyoPax with Prof. Simone Spuler.

In this Online SPARK Europe Webinar "Financing of early stage start-ups", Dr Marcin Szumowski will talk about the funding of early stage companies (medtech and drug development) and the long term effects of early funding decisions

In this Online SPARK Europe Webinar "IVDR compliant multicentric clinical performance study", Karolina Kašparová will discover the essential role of compliance with the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) in enhancing product quality.

SPARK Europe has joint forces for education on translational research and technology transfer! For the sixth time, European SPARK sites will host a joint webinar series during fall 2024.

In this Online SPARK Europe Webinar "Personalised Immunotherapy for Treatment of Rare Diseases", Dr. Regina Demlová will be exploring the vital role of personalised immunotherapy in the treatment of rare diseases.